GlassScriptPhysician profile
Jiho Han
NPI 1053815407
$63,110.91
in general payments reported to CMS, 2019-2025
29 companies · $60K in 2025
The $60K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2022: $986 · 2023: $1,318 · 2024: $602 · 2025: $60K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $57K · Food and Beverage: $3,936 · Travel and Lodging: $815 · Education: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $57,000.00 |
| Food and Beverage | $3,935.90 |
| Travel and Lodging | $814.83 |
| Education | $267.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $50,523.91 | 2022-2025 | General - Atherectomy, Clinical Trial Product, Avvigo Guidance System |
| Medtronic, INC. | $7,339.63 | 2023-2025 | Onyx Frontier, Symplicity G3, Invos |
| Abbott Laboratories | $1,881.28 | 2022-2025 | Optis, Ensite |
| Abiomed | $899.85 | 2022-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $336.29 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $267.69 | 2021-2023 | Brilinta, Farxiga |
| Terumo Medical Corporation | $253.33 | 2022-2025 | Metacross Otw, Tr Band, Angio-Seal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.68 | 2022-2024 | Lifevest |
| Pfizer INC. | $165.04 | 2023 | |
| Novartis Pharmaceuticals Corporation | $157.47 | 2023 | |
| Cvrx, INC. | $134.91 | 2023 | Barostim Neo System |
| Lantheus Medical Imaging, INC. | $113.77 | 2022-2023 | Definity |
| Amgen INC. | $107.44 | 2025 | Repatha |
| Janssen Pharmaceuticals, INC | $104.40 | 2021-2023 | Xarelto |
| Edwards Lifesciences Corporation | $88.77 | 2023-2024 | Sapien 3 Ultra Resilia, Pascal |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $84.40 | 2021-2025 | |
| Philips North America LLC | $70.84 | 2022 | |
| Alnylam Pharmaceuticals INC. | $66.62 | 2025 | Amvuttra |
| Asahi Intecc USA, INC. | $60.03 | 2025 | Asahi Coronary Wires |
| Merck Sharp & Dohme LLC | $47.25 | 2022-2023 | Verquvo |
| Cardiva Medical, INC. | $43.99 | 2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs |
| Angiodynamics, INC. | $41.00 | 2024 | Alphavac |
| E.R. Squibb & Sons, L.L.C. | $33.57 | 2023 | Camzyos |
| Cordis US Corp. | $24.36 | 2025 | Mynx Control Venous |
| Scpharmaceuticals INC. | $23.53 | 2023 | |
| Heartflow, INC. | $17.47 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $17.08 | 2023 | Inpefa |
| Zoll Circulation INC | $14.85 | 2022 | |
| Livanova USA, INC. | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jiho Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.